We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Crystallography Study Reveals Details of Angiotensin Receptor Structure

By LabMedica International staff writers
Posted on 11 May 2015
Print article
Image: This is an illustration of the effects of angiotensin on the AT1R (vasoconstriction, high blood pressure) compared to blocking the receptor (relaxed blood vessel, normal blood pressure) (Photo courtesy of USC - the University of Southern California).
Image: This is an illustration of the effects of angiotensin on the AT1R (vasoconstriction, high blood pressure) compared to blocking the receptor (relaxed blood vessel, normal blood pressure) (Photo courtesy of USC - the University of Southern California).
Researchers working with one of the world's most powerful free-electron X-ray lasers have established the crystal structure of the protein angiotensin II type 1 receptor (AT1R), an important blood pressure regulator in the human body.

Despite being the primary regulator for blood pressure maintenance, the structural basis for AT1R ligand-binding and regulation has remained elusive, mostly due to the difficulties of growing high-quality crystals for structure determination using synchrotron radiation. However, by applying the recently developed method of serial femtosecond crystallography at an X-ray free-electron laser, investigators at the University of Southern California (Los Angeles, USA) and their colleagues at Deutsches Elektronen-Synchrotron (Hamburg, Germany) successfully determined the room-temperature crystal structure of human AT1R in complex with its selective antagonist ZD7155 at 0.29 nanometers resolution.

The investigators wrote in a paper published in the April 23, 2015, online edition of the journal Cell that the AT1R-ZD7155 complex structure revealed key structural features of AT1R and critical interactions for ZD7155 binding. Docking simulations of the clinically used AT1R blockers (ARBs) into the AT1R structure further elucidated both the common and distinct binding modes for these anti-hypertensive drugs.

"Our work represents a first step in the direction of designing tailor-made blood pressure drugs with fewer side effects," said senior author Dr. Vadim Cherezov, professor of chemistry at the University of Southern California.

Related Links:

University of Southern California
Deutsches Elektronen-Synchrotron


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Liquid Based Cytology Production Machine
LBP-4032

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.